Gene expression profiles of idiopathic interstitial pneumonias: Identification of disease-specific diagnostic markers and molecular therapeutic targets

N. Ishikawa, N. Hattori, M. Taniwaki, Y. Horimasu, T. Matsuda, N. Kohno (Hiroshima, Japan)

Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Session: Idiopathic pulmonary fibrosis
Session type: Poster Discussion
Number: 3147
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Ishikawa, N. Hattori, M. Taniwaki, Y. Horimasu, T. Matsuda, N. Kohno (Hiroshima, Japan). Gene expression profiles of idiopathic interstitial pneumonias: Identification of disease-specific diagnostic markers and molecular therapeutic targets. Eur Respir J 2012; 40: Suppl. 56, 3147

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Gene expression profiling: can we identify the right target genes?
Source: Eur Respir Rev 2008; 17: 163-167
Year: 2008



A novel prognostic signature based on five-immune-related genes for idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021



Gene expression profiling: identifying novel gene targets for therapeutic intervention
Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow
Year: 2008



Candidate surrogate markers for COPD identified by differential gene expression
Source: Eur Respir J 2002; 20: Suppl. 38, 583s
Year: 2002

Novel method of expressing serum biomarkers profiling in COPD patients: The heatmap-clinical pattern profile
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Molecular endpoints for establishing target engagement by novel idiopathic pulmonary fibrosis therapies
Source: Eur Respir J, 53 (3) 1900283; 10.1183/13993003.00283-2019
Year: 2019



Imaging and molecular biomarkers: a novel approach to screen populations at risk of pulmonary fibrosis?
Source: Eur Respir J 2016; 48: 1271-1273
Year: 2016


Gene expression profiling identifies neutrophilic and eosinophilic asthma as distinct subtypes
Source: Eur Respir J 2007; 30: Suppl. 51, 526s
Year: 2007

Different expression profiles of gelsolin in various types of idiopathic interstitial pneumonias (IIPs). A tissue microarray study
Source: Eur Respir J 2007; 30: Suppl. 51, 573s
Year: 2007

Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Validation of a novel prognostic tool for idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012

Micro Array screening of microRNA markers of interstitial lung diseases for differential diagnostics.
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Differential expression of tenascin C splice variants in endobronchial epithelial-lining fluid in proximity of pulmonary nodules
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring
Source: Eur Respir J 2006; 28: Suppl. 50, 152s
Year: 2006

Role of microRNA 17/92 cluster and microRNA 21 in the pathogenesis of pulmonary hypertension – Novel therapeutic targets
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

LSC Abstract – microRNA profiling reveals a role for microRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016

Genetic studies as a tool for identifying novel potential targets for treatment of COPD
Source: Eur Respir J, 50 (5) 1702042; 10.1183/13993003.02042-2017
Year: 2017



Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014


Global gene expression analyses highlight the role of plasma membrane remodeling as a molecular functions of airway epithelium in response to interleukin-13 treatment
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015